Search for: "MAJOR PHARMACEUTICALS" Results 1021 - 1040 of 4,361
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 May 2019, 5:42 am by John Floyd
  Sending Shockwaves through the Industry   “[These] charges should send shockwaves throughout the pharmaceutical industry reminding them of their role as gatekeepers of prescription medication. [read post]
7 May 2019, 7:57 am by Thorsten Bausch
One simply cannot assert that even the simple majority of patents that are seriously attacked before the FPC will withstand nullity plaintiff’s challenges. [read post]
6 May 2019, 9:05 pm by Robert M. Kaplan
The Act was originated and promoted by the major pharmaceutical companies who employed over 1,300 lobbyists to promote the bill. [read post]
30 Apr 2019, 7:22 am
  Prior to 2017, Canada had been the only G7 nation not to provide patent term extension for pharmaceutical products and was pressured into adopting this by the EU. [read post]
30 Apr 2019, 6:05 am by Patrick A. Malone
The legal war, however, has resulted in aggressive steps by federal prosecutors accusing not only scores of doctors across seven states with improperly prescribing painkillers for cash and sex, but also with officials filing for the first time drug-trafficking charges against a major pharmaceutical distributor and two of its former executives. [read post]
28 Apr 2019, 7:45 am
   Whilst there was a split decision on plausibility / sufficiency of the claims covering neuropathic pain, the majority view was that neither the treatment of peripheral nor central neuropathic pain with pregabalin was plausible:The “patent bargain” was emphasised:  patent monopoly must be in return for disclosing the invention. [read post]
26 Apr 2019, 10:07 am by admin
  This week, for the first time, federal prosecutors brought felony charges against a major pharmaceutical distributor, its former CEO and another executive related to the opioid crisis. [read post]
26 Apr 2019, 1:45 am by Sean Hayes
Major provisions of the Korean Act on Financial Transaction Information The purpose of the Act on Reporting and Using Specified Financial Transaction Information is to “…provide for matters concerning reporting on and use of specified financial transaction information necessary to regulate money laundering and financing of terrorism through financial transactions, such as foreign exchange transactions, thereby contributing to preventing crimes and further establishing a… [read post]
25 Apr 2019, 1:00 pm
  Although a split Congress (Republican Senate and Democratic House), both have focused attention on the pharmaceutical industry. [read post]
24 Apr 2019, 9:46 pm by Sean Hayes
Major provision of the Amendment to the Act on Overseas Expansion of Healthcare in Korea As mentioned above, to be able to create and run proper follow-up programs, this bill seeks to offer a legal basis for the establishment of a national database of medical training programs for foreign medical service workers. [read post]
23 Apr 2019, 6:00 pm by Metric Marketing
You may have heard about class action lawsuits in the news when pharmaceutical drugs cause injuries or data breaches of major corporations. [read post]
22 Apr 2019, 9:01 pm by Neil H. Buchanan
It sometimes seems that every issue of a major paper these days includes news articles that embed slanted or unfavorable treatment of Sanders and his allies into what sounds like fact-based reportage.For example, a Post article last week regarding Democratic leaders’ response to Trump’s dangerous escalation of right-wing attacks on Representative Ilhan Omar of Minnesota begins with these words: “The far left’s frustration with House Speaker Nancy Pelosi is on the… [read post]
15 Apr 2019, 5:53 am by Litigation news
Consumers, pharmacies, and healthcare facilities that have product being recalled should stop using and dispensing the product immediately.Consumers with questions regarding this recall should contact Rugby Laboratories/Major Pharmaceuticals Customer Support at 1-800-645-2158, available Monday through Friday 8 a.m. [read post]
13 Apr 2019, 12:25 pm
| PI awarded following disagreement with EPO on added matter - Novartis v Dr Reddy's | Court of Appeal reaffirms English Court as forum for SEP disputes | The novelty of “on sale inventions” under a confidentiality agreement with regards to an “on sale” invention: the US Supreme Court rules | China IP Office released major IP statistics of 2018 | New Chinese E-Commerce Law and its impact on IPR protection | Hola, I will have the IP--and a shot of Tequila |… [read post]
12 Apr 2019, 2:35 pm by opseo
And once the petition was issued, a simple majority of those landholders could vote to create the MMD and seek the required approval from the City Council and Texas Legislature. [read post]
11 Apr 2019, 9:05 pm by Alana Bevan
The memo clarifies that OIRA will determine if a rule is major even if its economic impact is below the usual $100 million threshold so long as it triggers a major increase in costs or entails significant adverse effects on the U.S. economy. [read post]